Alignment CIO sells shares for tax withholding

Alignment Healthcare, Inc. Chief Information Officer Robert L. Scavo reported an open-market sale of 11,285 shares of common stock.

Accepted by SEC EDGAR 03/19/2026 - 06:26 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Alignment Healthcare, Inc. Chief Information Officer Robert L. Scavo reported an open-market sale of 11,285 shares of common stock. The shares were sold primarily to cover tax withholding obligations tied to the vesting of restricted stock units, so the transaction was not a discretionary trade. The weighted-average sale price was $17.84 per share, with individual trades ranging from $17.40 to $18.24. After this tax-related sale, Scavo holds 487,685 shares of Alignment Healthcare common stock directly.

Insider Trade Summary

Net Seller: 11,285 shares

Net Sell 1 txn

Insider Scavo Robert L.

Role Chief Information Officer

Sold 11,285 shs ($201K)

Type	Security	Shares	Price	Value
Sale	Common Stock	11,285	$17.84	$201K

Holdings After Transaction: Common Stock — 487,685 shares (Direct)

Footnotes (2)

1. F1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
2. F2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Alignment Healthcare (ALHC) report on this Form 4?

Alignment Healthcare reported that Chief Information Officer Robert L. Scavo sold 11,285 shares of common stock. The sale was linked to tax withholding obligations from vesting restricted stock units, rather than a discretionary decision to reduce his investment position.

Why did Alignment Healthcare CIO Robert L. Scavo sell 11,285 ALHC shares?

The 11,285 shares were sold to cover tax withholding obligations arising from the vesting of restricted stock units. The filing states this transaction does not represent a discretionary trade, indicating it was a mechanistic, tax-driven event rather than an active portfolio decision.

What price did Robert L. Scavo receive for the sold Alignment Healthcare shares?

The reported weighted-average sale price was $17.84 per share for the 11,285 sold shares. According to the filing, individual trades occurred at prices ranging from $17.40 to $18.24, with full trade-by-trade details available upon request from the company or regulators.

How many Alignment Healthcare (ALHC) shares does the CIO hold after this Form 4 sale?

Following the tax-related sale, Robert L. Scavo directly holds 487,685 shares of Alignment Healthcare common stock. This remaining stake provides context, showing the reported sale represents a relatively small portion of his overall direct share ownership in the company.

Was the Alignment Healthcare CIO’s Form 4 sale a discretionary trade?

No. The footnotes explain that the 11,285 shares were sold to satisfy tax withholding obligations from vesting restricted stock units. The filing explicitly notes that this transaction does not represent a discretionary trade by Robert L. Scavo in Alignment Healthcare stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Scavo Robert L.

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CALIFORNIA 92868

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Information Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		S		11,285(1)	D	$17.84(2)	487,685	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Robert L. Scavo	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)